Life’s work of artist whose career was cut short by NET
The Heritage of Sherborn, MA, will host a Retrospective Art Show and final sale of works by late artist, Carl Schaad (1946 – 2011). The three-month exhibit opens with a reception from 5:30 -7:30 pm on Tuesday, September 10, 2019. Approximately 30 oil paintings and 11 giclee limited edition prints will be for sale through November 30, 2019.
At 64, Carl succumbed to neuroendocrine cancer. His family curated three decades of his work for this retrospective show and sale, with a portion benefiting the Neuroendocrine Tumor Research Foundation (NETRF) to advance neuroendocrine cancer outreach and education.
“We are hoping to make a difference for other patients and families—increased awareness and early diagnosis are important,” said Nancy Schaad, Carl’s wife. Nancy says the lack of awareness about neuroendocrine tumors contributes to misdiagnosis and delayed diagnosis. “While working on this show I wondered what other beautiful paintings would have been created if Carl’s cancer had been found earlier?”
Neuroendocrine tumor (NET) symptoms are commonly mistaken for other conditions such as irritable bowel syndrome, colitis, or asthma.
- One in two neuroendocrine tumor patients is misdiagnosed.1
- On average, people have symptoms for five years before learning they have a neuroendocrine tumor.1
- More than half of NETs spread beyond the primary site before they are diagnosed.1
A decade of mysterious NET symptoms
Carl’s neuroendocrine tumor diagnosis was incidental. In 2007, he was hit by an SUV while training to ride a portion of the famed Giro D’Italia, a multi-stage bicycle race in Italy (a country he loved to visit and paint). He was airlifted to the hospital with 33 breaks to his ribs, a collapsed lung, and head hematoma. A diagnostic CT scan also found neuroendocrine cancer, which had spread to his liver.
Carl’s neuroendocrine cancer diagnosis explained ten years of mysterious symptoms: unexplained stomach cramping and diarrhea, flushing, and shortness of breath. Since the neuroendocrine tumors were outside of the colon, they were never detected by colonoscopy. Instead, he was diagnosed with irritable bowel syndrome.
“In the months before the accident, he would go out for a century bike ride and be fine. Then, after coming up the basement stairs, he would wheeze and be out of breath. It made no sense for such a big, strong guy,” said Nancy.
Following his diagnosis, Carl connected with the founder of NETRF, both had been diagnosed with the same disease. At NETRF, he found information and support during his four and a half years of treatment.
Impressionist-inspired works of art
Carl captured landscapes and still life scenes on canvas in a subtle color palette. With a strong command of light as a means of conveying emotion, Carl’s work pulls viewers in to experience Montalcino’s bell towers ringing, a young boy dipping his toy boat in the waters of Rhode Island’s shore, or a May wind swirling Tuscany’s red poppies. His lyrical craftsmanship creates a meditative mood of ordinary scenes.
He was moved by impressionists Berthe Morisot and Mary Cassatt. He favored realism and a classical approach leaning toward American Impressionism. Most weekends Carl could be found painting “en plein air” in rural and coastal settings.
A lifelong love of painting
Carl had an unusual career for an artist. He began seriously painting in his 30s while also working in the corporate world, eventually rising to senior leadership levels at Heidrick & Struggles, a global executive search firm. Throughout his business career, Carl continued his art studies at The Museum School of Boston, The Art Guild of Boston, and the Ingbretson Atelier. He studied with Robert Cormier, William Bartlett, mentor/friend William Ternes, Joseph McGurl, and Mary Minifie.
At age 55, he left the corporate world to paint full time. Finally able to follow his passion, he sculpted beautiful images with paint for close to a decade before his death.
Take advantage of this one-time opportunity to purchase one of Carl’s oil paintings or giclee prints, visit www.carlschaadart.com. A portion of all proceeds will support NETRF.
1Singh S, Granberg D, Wolin E, et al. Patient-reported burden of a neuroendocrine tumor (NET) diagnosis: results from the first global survey of patients with NETs. J Glob Oncol. 2016;2(1):43-53.